Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology
NCT02702271
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
458
Enrollment
INDUSTRY
Sponsor class
Conditions
Atrial Fibrillation
Interventions
DEVICE:
WATCHMAN FLX
Sponsor
Boston Scientific Corporation